Melatonin inhibits the Migration of Colon Cancer RKO cells by Down-regulating Myosin Light Chain Kinase Expression through Cross-talk with p38 MAPK |
Zou, Duo-Bing
(Laboratory of Molecular Biology and Department of Biochemistry, Anhui Medical University)
Wei, Xiao (Laboratory of Molecular Biology and Department of Biochemistry, Anhui Medical University) Hu, Ruo-Lei (Laboratory of Molecular Biology and Department of Biochemistry, Anhui Medical University) Yang, Xiao-Ping (Laboratory of Molecular Biology and Department of Biochemistry, Anhui Medical University) Zuo, Li (Laboratory of Molecular Biology and Department of Biochemistry, Anhui Medical University) Zhang, Su-Mei (Laboratory of Molecular Biology and Department of Biochemistry, Anhui Medical University) Zhu, Hua-Qing (Laboratory of Molecular Biology and Department of Biochemistry, Anhui Medical University) Zhou, Qing (Laboratory of Molecular Biology and Department of Biochemistry, Anhui Medical University) Gui, Shu-Yu (Key Laboratory of Gene Research of Anhui Province) Wang, Yuan (Laboratory of Molecular Biology and Department of Biochemistry, Anhui Medical University) |
1 | Joo SS, and Yoo YM (2009). Melatonin induces apoptotic death in LNCaP cells via p38 and JNK pathways: therapeutic implications for prostate cancer. J Pineal Res, 47, 8-14. DOI |
2 | Kaneko K, Satoh K, Masamune A, et al (2002). Myosin light chain kinase inhibitors can block invasion and adhesion of human pancreatic cancer cell lines. Pancreas, 24, 34-41. DOI |
3 | Katzer D, Mueller A, Welzing L, et al (2015). Antioxidative status and oxidative stress in the fetal circulation at birth: the effects of time of delivery and presence of labor. Early Hum Dev, 91, 119-24. DOI |
4 | Klemke RL, Cai S, Giannini AL, et al (1997). Regulation of cell motility by mitogen-activated protein kinase. J Cell Biol, 137, 481-92. DOI |
5 | Kolega J (2003). Asymmetric distribution of myosin IIB in migrating endothelial cells is regulated by a rho-dependent kinase and contributes to tail retraction. Mol Biol Cell, 14, 4745-57. DOI ScienceOn |
6 | Kucharczak J, Pannequin J, Camby I, et al (2001). Gastrin induces over-expression of genes involved in human U373 glioblastoma cell migration. Oncogene, 20, 7021-28. DOI |
7 | Lai JM, Hsieh CL, and Chang ZF (2003). Caspase activation during phorbol ester-induced apoptosis requires ROCKdependent myosin-mediated contraction. J Cell Sci, 116, 3491-501. DOI |
8 | Lee YJ, Lee JH, Moon JH, and Park SY (2014). Overcoming hypoxic-resistance of tumor cells to TRAIL-induced apoptosis through melatonin. Int J Mol Sci, 15, 11941-56. DOI |
9 | Liu L, Zhu Y, Xu Y and Reiter RJ (2012). Prevention of ERK activation involves melatonin-induced G1 and G2/M phase arrest in the human osteoblastic cell line hFOB 1.19. J Pineal Res, 53, 60-6. DOI |
10 | Mao L, Yuan L, Slakey LM, et al (2010). Inhibition of breast cancer cell invasion by melatonin is mediated through regulation of the p38 mitogen-activated protein kinase signaling pathway. Breast Cancer Res, 12, 107. DOI |
11 | Martin V, Herrera F, Carrera-Gonzalez P, et al (2006). Intracellular Signaling Pathways Involved in the Cell Growth Inhibition of Glioma Cells by Melatonin. Cancer Res, 66, 1081-8. DOI |
12 | Mills AM, Beck AH, Montgomery KD, et al (2011). Expression of subtype-specific group 1 leiomyosarcoma markers in a wide variety of sarcomas by gene expression analysis and immunohistochemistry. Am J Surg Pathol, 35, 583-9. DOI ScienceOn |
13 | Ordonez R, Carbajo-Pescador S, Prieto-Dominguez N, et al (2014). Inhibition of matrix metalloproteinase-9 and nuclear factor kappa B contribute to melatonin prevention of motility and invasiveness in HepG2 liver cancer cells. J Pineal Res, 56, 20-30. DOI |
14 | Ortiz-Lopez L, Morales-Mulia S, Ramirez-Rodriguez G and Benitez-King G (2009). ROCK-regulated cytoskeletal dynamics participate in the inhibitory effect of melatonin on cancer cell migration. J Pineal Res, 46, 15-21. DOI |
15 | Pitchakarn P, Chewonarin T, Ogawa K, et al (2013). Ellagic Acid inhibits migration and invasion by prostate cancer cell lines. Asian Pac J Cancer Prev, 14, 2859-63. DOI ScienceOn |
16 | Plaimee P, Khamphio M, Weerapreeyakul N, et al (2014a). Immunomodulatory effect of melatonin in SK-LU-1 human lung adenocarcinoma cells co-cultured with peripheral blood mononuclear cells. Cell Prolif, 47, 406-15. DOI |
17 | Plaimee P, Weerapreeyakul N, Thumanu K, et al (2014b). Melatonin induces apoptosis through biomolecular changes, in SK-LU-1 human lung adenocarcinoma cells. Cell Prolif, 47, 564-77. DOI |
18 | Srinivasan V, Pandi-Perumal SR, Brzezinski A, et al (2011). Melatonin, Immune Function and Cancer. Recent Pat Endocr Metab Immune Drug Discov, 5, 109-23. DOI |
19 | Reiter RJ (1991). Pincal melatonin: cell biology of its synthesis and of its physiological interactions. Endocr Rev, 12, 151-80. DOI |
20 | Shin EJ, Chung YH, Le HL, et al (2014). Melatonin attenuates memory impairment induced by klotho gene deficiency via interactive signaling between MT2 receptor, ERK and Nrf2- related antioxidant potential. Int J Neuropsychopharmacol, 18, 105. |
21 | Sun C, Wu MH, and Yuan SY (2011). Nonmuscle myosin light-chain kinase deficiency attenuates atherosclerosis in apolipoprotein E-deficient mice via reduced endothelial barrier dysfunction and monocyte migration. Circulation, 124, 48-57. DOI ScienceOn |
22 | Tanaka T, Yasui Y, Tanaka M, et al (2009). Melatonin suppresses AOM/DS -induced large bowel oncogenesis in rats. Chem Biol Interact, 177, 128-36. DOI |
23 | Vasiliev JM (2004). Cytoskeletal mechanisms responsible for invasive migration of neoplastic cells. Int J Dev Biol, 48, 425-39. DOI |
24 | Vellinga TT, Borovski T, de Boer VC, et al (2015). SIRT1/PGC1 dependent increase in oxidative phosphorylation supports chemotherapy resistance of colon cancer. Clin Cancer Res, 21, 2870-9 DOI |
25 | Verma D, Hashim OH, Jayapalan JJ, and Subramanian P (2014). Effect of melatonin on antioxidant status and circadian activity rhythm during hepatocarcinogenesis in mice. J Cancer Res Ther, 10, 1040-4. DOI |
26 | Viala E, and Pouysségur J et al (2004). Regulation of tumor cell motility by ERK mitogen-activated protein kinases. Ann N Y Acad Sci, 1030, 208-18. DOI |
27 | Wang J, Guo W, Chen W, et al (2013c). Melatonin potentiates the antiproliferative and pro-apoptotic effects of ursolic acid in colon cancer cells by modulating multiple signaling pathways. J Pineal Res, 54, 406-16. |
28 | Vicente-Manzanares M, Zareno J, Whitmore L, et al (2007). Regulation of protrusion, adhesion dynamics, and polarity by myosins IIA and IIB in migrating cells. J Cell Biol, 176, 573-80. DOI |
29 | Wang B, Yan Y, Zhou J, et al (2013a). A novel all-trans retinoid acid derivatives inhibits the migration of breast cancer cell lines MDA-MB-231 via myosin light chain kinase involving p38-MAPK pathway. Biomed Pharmacother, 67, 357-62. DOI ScienceOn |
30 | Wang H, Gui SY, Chen FH, et al (2013b). New Insights into 4-Amino-2-tri-fluoromethyl-phenyl Ester Inhibition of Cell Growth and Migration in the A549 Lung Adenocarcinoma Cell Line. Asian Pac J Cancer Prev, 14, 7265-70. DOI ScienceOn |
31 | Wang J, Hao H, Yao L, et al (2012d). Melatonin suppresses migration and invasion via inhibition of oxidative stress pathway in glioma cells. J Pineal Res, 53, 180-7. DOI |
32 | Wenzel U, Nickel A, and Daniel H (2005). Melatonin potentiates flavoneinduced apoptosis in human colon cancer cells by increasing the level of glycolytic end products. Int J Cancer, 116, 236-42. DOI |
33 | Wilson AK, Gorgas G, Claypool WD, and de Lanerolle P (1991). An increase or a decrease in myosin II phosphorylation inhibits macrophage motility. J Cell Biol, 114, 277-83. DOI |
34 | Winczyk K, Fuss-Chmielewska J, Lawnicka H, et al (2009). Luzindole but not 4-phenyl-2- propionamidotetralin (4P-PDOT) diminishes the inhibitory effect of melatonin on murine Colon 38 cancer growth in vitro. Neuro Endocrinol Lett, 30, 657-62. |
35 | Arechederra M, Priego N, Vazquez-Carballo A, et al (2015). p38 MAPK down-regulates fibulin 3 expression through methylation of gene regulatory sequences: Role in migration and invasion. J Biol Chem, 290, 4383-97. DOI |
36 | Akbulut KG, Aktas SH and Akbulut H (2015). The role of melatonin, sirtuin2 and FoXO1 transcription factor in the aging process of colon in male rats. Biogerontol, 16, 99-108. DOI |
37 | Andre T, Boni C, Mounedji-Boudiaf L, et al (2004). Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med, 350, 2343-51. DOI |
38 | Arafat K, Iratni R, Takahashi T, et al (2013). Inhibitory effects of salinomycin on cell survival, colony growth, migration, and invasion of human non-small cell lung cancer A549 and LNM35: Involvement of NAG-1. PLoS One, 8, 66931. DOI ScienceOn |
39 | Blask DE (2009). Melatonin, sleep disturbance and cancer risk. Sleep Medicine Rev, 13, 257-64. DOI |
40 | Borges Lda S, Dermargos A, Junior EP, et al (2015). Melatonin decreases muscular oxidative stress and inflammation induced by strenuous exercise and stimulates growth factor synthesis. J Pineal Res, 58, 166-72. DOI |
41 | Chen C, Tao T, Wen C, et al (2014). Myosin Light Chain Kinase (MLCK) Regulates Cell Migration in a Myosin Regulatory Light Chain Phosphorylation-Independent Mechanism. J Biol Chem, 289, 28478-88. DOI |
42 | Chew TL, Wolf WA, Gallagher PJ, et al (2002). A fluorescent resonant energy transfer-based biosensor reveals transient and regional myosin light chain kinase activation in lamella and cleavage furrows. J Cell Biol, 156, 543-53. DOI ScienceOn |
43 | Zha L, Fan L, Sun G, et al (2012). Melatonin sensitizes human hepatoma cells to endoplasmic reticulum stress-induced apoptosis. J Pineal Res, 52, 322-31. DOI |
44 | Yan X, Rui X, and Zhang K (2015). Baicalein inhibits the invasion of gastric cancer cells by suppressing the activity of the p38 signaling pathway. Oncol Rep, 33, 737-43. |
45 | Yi C, Zhang Y, Yu Z, et al (2014). Melatonin enhances the antitumor effect of fisetin by inhibiting COX-2/iNOS and NFkB/ p300 signaling pathways. PLoS One, 9, 99943. DOI |
46 | Yun M, Kim EO, Lee D, et al (2014). Melatonin sensitizes H1975 non-small-cell lung cancer cells harboring a T790M-targeted epidermal growth factor receptor mutation to the tyrosine kinase inhibitor gefitinib. Cell Physiol Biochem, 34, 865-72. DOI |
47 | Zhou Q, Gui S, Zhou Q, et al (2014a). Melatonin Inhibits the Migration of Human Lung Adenocarcinoma A549 Cell Lines Involving JNK/MAPK Pathway. PLoS One, 9, 101132. DOI |
48 | Zhou X, Liu Y, You J, et al (2008b). Myosin light-chain kinase contributes to the proliferation and migration of breast cancer cells through cross-talk with activated ERK1/2. Cancer Lett, 270, 312-27. DOI |
49 | Zhu P, Chen JM, Guo HM, et al (2012). Matrine inhibits disturbed flow-enhanced migration via downregulation of ERK1/2-MLCK signaling vascular smooth muscle cells. Ann Vasc Surg, 26, 268-75. DOI ScienceOn |
50 | Claustrat B, Brun J, and Chazot G (2005). The basic physiology and pathophysiology of melatonin. Sleep Med Rev, 9, 11-24. DOI ScienceOn |
51 | Cumaoglu A, Dayan S, Agkaya AO, et al (2014). Synthesis and pro-apoptotic effects of new sulfonamide derivatives via activating p38/ERK phosphorylation in cancer cells. J Enzyme Inhib Med Chem, 8, 1-7. |
52 | Del Reino P, Alsina-Beauchamp D, Escos A, et al (2014). Prooncogenic role of alternative p38 mitogen-activated protein kinases and , linking inflammation and cancer in colitis-associated colon cancer. Cancer Res, 74, 6150-60. DOI |
53 | Even-Ram S, Doyle AD, Conti MA, et al (2007). Myosin IIA regulates cell motility and actomyosin-microtubule crosstalk. Nat Cell Biol, 9, 299-309. DOI |
54 | Fan TT, Cheng Y, Wang YF, et al (2014). A Novel All-trans Retinoid Acid Derivative N- (3-trifluoromethyl-phenyl)- Retinamide Inhibits Lung Adenocarcinoma A549 Cell Migration through Down-regulating Expression of Myosin Light Chain Kinase. Asian Pac J Cancer Prev, 15, 7687-92. DOI |
55 | Garcia-Navarro A, Gonzalez-Puga C, Escames G, et al (2007). Cellular mechanisms involved in the melatonin inhibition of HT-29 human colon cancer cell proliferation in culture. J Pineal Res, 43, 195-205. DOI |
56 | Grossi V, Peserico A, Tezil T, et al (2014). MAPK pathway: a key factor in colorectal cancer therapy and chemoresistance. World J Gastroenterol, 20, 9744-58. DOI |
57 | Gu LZ, Hu WY, Antic N, et al (2011). Inhibiting myosin light chain kinase retards the growth of mammary and prostate cancer cells. Eur J Cancer, 42, 948-57. |
58 | Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69 90. |